HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Chemotherapy for esophageal cancer].

Abstract
Esophageal cancer is supposed to be more sensitive to chemotherapy compared to other gastrointestinal cancers. Since cisplatin (CDDP) was developed, it has become a key drug for combined chemotherapy. At present, the combination of CDDP and 5-fluorouracil (5-FU) is the standard regimen for the treatment of esophageal carcinoma. Nedaplatin (CDGP) and paclitaxel (TXL) have shown favorable results either as a single agent or in combination with CDDP. Comparisons of drug efficacy between these new regimens and CDDP/5-FU in more cases has yet to be carried out. However, since esophageal cancer can hardly be cured by definitive chemotherapy alone, chemotherapy plays an important role in the multimodality therapy for esophageal cancer. The results of definitive chemoradiotherapy for advanced esophageal cancer has recently improved. The efficacy of preoperative (neoadjuvant) chemoradiotherapy in terms of survival benefit still remains controversial according to a meta-analysis of large-scale, randomized controlled trials (RCTs) when compared with surgery alone. A RCT completed by the Japan Clinical Oncology Group (JCOG) demonstrated the prognostic benefit of postoperative adjuvant chemotherapy for disease-free survival in comparison to surgery alone. Another RCT by JCOG has been conducted to clarify whether preoperative or postoperative chemotherapy may have a prognostic benefit in patients who undergo an esophagectomy.
AuthorsYoshihiro Nabeya, Takenori Ochiai
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 30 Issue 12 Pg. 1873-80 (Nov 2003) ISSN: 0385-0684 [Print] Japan
PMID14650953 (Publication Type: Journal Article, Review)
Chemical References
  • Bleomycin
  • Mitomycin
  • Vinblastine
  • Cisplatin
  • Vinorelbine
  • Fluorouracil
Topics
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Bleomycin (administration & dosage)
  • Cisplatin (administration & dosage)
  • Esophageal Neoplasms (drug therapy, mortality, surgery)
  • Fluorouracil (administration & dosage)
  • Humans
  • Mitomycin (administration & dosage)
  • Neoadjuvant Therapy
  • Randomized Controlled Trials as Topic
  • Survival Rate
  • Vinblastine (administration & dosage, analogs & derivatives)
  • Vinorelbine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: